新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jfr therapy [26 articles]

最近 jfr さんのライブラリに追加された論文の中から タグ therapy. You can also see everyone's therapy.
  • Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
    JAMA : the journal of the American Medical Association, Vol. 299, No. 13. (2 April 2008), pp. 1574-1587.
    by CR Acharya, DS Hsu, CK Anders, A Anguiano, KH Salter, KS Walters, RC Redman, SA Tuchman, CA Moylan, S Mukherjee, WT Barry, HK Dressman, GS Ginsburg, KP Marcom, KS Garman, GH Lyman, JR Nevins, A Potti
    posted to therapy gene_expression classification breast_cancer bio_signature by jfr on 2008-05-16 10:17:02 as read along with 1 person jyuh
  • Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
    Breast cancer research and treatment (9 March 2008)
    by Djuana M Harvell, Nicole S Spoelstra, Meenakshi Singh, James L McManaman, Christina Finlayson, Tzu Phang, Susan Trapp, Lawrence Hunter, Wendy W Dye, Virginia F Borges, Anthony Elias, Kathryn B Horwitz, Jennifer K Richer
    posted to breast_cancer classification therapy by jfr on 2008-04-14 16:48:35 as **
  • Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 22. (1 August 2007), pp. 3230-3237.
    by S Khambata-Ford, CR Garrett, NJ Meropol, M Basik, CT Harbison, S Wu, TW Wong, X Huang, CH Takimoto, AK Godwin, BR Tan, SS Krishnamurthi, HA Burris, EA Poplin, M Hidalgo, J Baselga, EA Clark, DJ Mauro
    posted to classification colon_cancer gene_expression therapy by jfr on 2008-04-09 13:55:11 as ****
  • Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 7. (1 March 2007), pp. 773-780.
    by M Del Rio, F Molina, C Bascoul-Mollevi, V Copois, F Bibeau, P Chalbos, C Bareil, A Kramar, N Salvetat, C Fraslon, E Conseiller, V Granci, B Leblanc, B Pau, P Martineau, M Ychou
    posted to colon_cancer gene_expression therapy by jfr on 2008-04-09 13:19:40 as read
  • MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
    JAMA, Vol. 299, No. 4. (30 January 2008), pp. 425-436.
    by AJ Schetter, SY Leung, JJ Sohn, KA Zanetti, ED Bowman, N Yanaihara, ST Yuen, TL Chan, DL Kwong, GK Au, CG Liu, GA Calin, CM Croce, CC Harris
    posted to colon_cancer mirna prognosis therapy by jfr on 2008-03-11 10:36:19 as read
  • Drug[mdash]target network
    Nat Biotech, Vol. 25, No. 10. (October 2007), pp. 1119-1126.
    by Muhammed A Yildirim, Kwang-Il Goh, Michael E Cusick, Albert-Laszlo Barabasi, Marc Vidal
    posted to network therapy by jfr on 2008-02-04 11:41:06 as **** along with 9 people and 1 group Yanno jyuh cannin julius grahamc cjeans zwang dejori mingzhi libr
  • Molecular subtyping of breast cancer: opportunities for new therapeutic approaches.
    Cell Mol Life Sci (22 October 2007)
    by P B Mullan, R C Millikan
    posted to breast_cancer review subtypes therapy by jfr on 2007-12-17 12:20:27 as ****
  • Pharmacogenomic predictor discovery in phase II clinical trials for breast cancer.
    Clin Cancer Res, Vol. 13, No. 20. (15 October 2007), pp. 6080-6086.
    by L Pusztai, K Anderson, KR Hess
    posted to breast_cancer classification her2 therapy by jfr on 2007-12-17 12:16:16 as read
  • Pharmacogenomic Strategies Provide a Rational Approach to the Treatment of Cisplatin-Resistant Patients With Advanced Cancer
    J Clin Oncol, Vol. 25, No. 28. (1 October 2007), pp. 4350-4357.
    by David S Hsu, Bala S Balakumaran, Chaitanya R Acharya, Vanja Vlahovic, Kelli S Walters, Katherine Garman, Carey Anders, Richard F Riedel, Johnathan Lancaster, David Harpole, Holly K Dressman, Joseph R Nevins, Phillip G Febbo, Anil Potti
    posted to lung_cancer therapy treatment by jfr on 2007-12-07 17:15:15 as *** along with 1 person leonnovelo
  • Trastuzumab--mechanism of action and use in clinical practice.
    N Engl J Med, Vol. 357, No. 1. (5 July 2007), pp. 39-51.
    by CA Hudis
    posted to breast_cancer review therapy treatment by jfr on 2007-12-06 09:57:50 as *** along with 1 person jyuh
  • Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer.
    Clin Cancer Res, Vol. 13, No. 14. (15 July 2007), pp. 4078-4082.
    by F Peintinger, K Anderson, C Mazouni, HM Kuerer, C Hatzis, F Lin, GN Hortobagyi, WF Symmans, L Pusztai
    posted to breast_cancer therapy by jfr on 2007-12-06 08:52:59 as ***
  • A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery.
    Proc Natl Acad Sci U S A, Vol. 104, No. 32. (7 August 2007), pp. 13086-13091.
    by JK Lee, DM Havaleshko, H Cho, JN Weinstein, EP Kaldjian, J Karpovich, A Grimshaw, D Theodorescu
    posted to therapy by jfr on 2007-12-04 11:50:12 as read along with 1 person oelemento
  • Molecular response to aromatase inhibitor treatment in primary breast cancer
    Breast Cancer Research, Vol. 9 (07 June 2007), R37.
    by Alan G Mackay, Ander Urruticoechea, JM Dixon, Tim Dexter, Kerry Fenwick, Alan Ashworth, Suzanne Drury, Alexey Larionov, Oliver Young, Sharon White, William R Miller, Dean B Evans, Mitch Dowsett
    posted to breast_cancer therapy by jfr on 2007-11-28 13:07:54 as ****
  • Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy.
    Eur J Cancer, Vol. 42, No. 16. (November 2006), pp. 2729-2737.
    by E Niméus-Malmström, C Ritz, P Edén, A Johnsson, M Ohlsson, C Strand, G Ostberg, M Fernö, C Peterson
    posted to breast_cancer classification therapy by jfr on 2007-11-23 15:01:07 as ****
  • Triple-negative breast cancer: therapeutic options.
    Lancet Oncol, Vol. 8, No. 3. (March 2007), pp. 235-244.
    by S Cleator, W Heller, RC Coombes
    posted to basal_subtype breast_cancer review therapy by jfr on 2007-06-26 16:13:30 as **
  • Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
    J Clin Oncol, Vol. 24, No. 26. (10 September 2006), pp. 4236-4244.
    by KR Hess, K Anderson, WF Symmans, V Valero, N Ibrahim, JA Mejia, D Booser, RL Theriault, AU Buzdar, PJ Dempsey, R Rouzier, N Sneige, JS Ross, T Vidaurre, HL Gómez, GN Hortobagyi, L Pusztai
    posted to breast_cancer chemo classification therapy by jfr on 2007-05-10 15:12:40 as read along with 1 person giovenko
  • Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.
    J Clin Oncol, Vol. 24, No. 12. (20 April 2006), pp. 1839-1845.
    by O Thuerigen, A Schneeweiss, G Toedt, P Warnat, M Hahn, H Kramer, B Brors, C Rudlowski, A Benner, F Schuetz, B Tews, R Eils, HP Sinn, C Sohn, P Lichter
    posted to breast_cancer chemo classification therapy by jfr on 2007-05-10 15:11:39 as ***
  • Genomic prediction of locoregional recurrence after mastectomy in breast cancer.
    J Clin Oncol, Vol. 24, No. 28. (1 October 2006), pp. 4594-4602.
    by SH Cheng, CF Horng, M West, E Huang, J Pittman, MH Tsou, H Dressman, CM Chen, SY Tsai, JJ Jian, MC Liu, JR Nevins, AT Huang
    posted to breast_cancer therapy by jfr on 2007-03-23 14:30:31 as ***
  • DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design.
    Biochim Biophys Acta, Vol. 1766, No. 2. (December 2006), pp. 197-204.
    by F Andre, C Mazouni, GN Hortobagyi, L Pusztai
    posted to breast_cancer classification review therapy by jfr on 2007-03-01 13:10:41 as read
  • What clinicians need to know about antioestrogen resistance in breast cancer therapy.
    Eur J Cancer, Vol. 42, No. 16. (November 2006), pp. 2692-2705.
    by A Milano, L Dal Lago, C Sotiriou, M Piccart, F Cardoso
    posted to breast_cancer review serm therapy by jfr on 2007-03-01 11:34:07 as ****
  • Predictive factors for response to docetaxel in human breast cancers
    Cancer Science, Vol. 97, No. 9. (September 2006), pp. 813-820.
    by Noguchi, Shinzaburo
    posted to breast_cancer therapy by jfr on 2007-03-01 11:27:39 as ****
  • The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
    J Clin Oncol, Vol. 24, No. 28. (1 October 2006), pp. 4611-4619.
    by XJ Ma, SG Hilsenbeck, W Wang, L Ding, DC Sgroi, RA Bender, CK Osborne, DC Allred, MG Erlander
    posted to therapy tamoxifen classification breast_cancer by jfr on 2007-02-06 17:55:06 as read
  • Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy.
    Clin Cancer Res, Vol. 12, No. 3 Pt 2. (1 February 2006)
    by S Paik
    posted to therapy rt-pcr review ffpe breast_cancer by jfr on 2007-02-06 14:32:12 as read
  • Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy.
    Clin Cancer Res, Vol. 12, No. 3 Pt 1. (1 February 2006), pp. 819-826.
    by HK Dressman, C Hans, A Bild, JA Olson, E Rosen, PK Marcom, VB Liotcheva, EL Jones, Z Vujaskovic, J Marks, MW Dewhirst, M West, JR Nevins, K Blackwell
    posted to therapy classification breast_cancer by jfr on 2007-02-06 12:06:51 as ***
  • Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?
    Clin Cancer Res, Vol. 11, No. 13. (1 July 2005), pp. 4835-4842.
    by S Tovey, B Dunne, CJ Witton, A Forsyth, TG Cooke, JM Bartlett
    posted to therapy breast_cancer by jfr on 2007-01-18 14:23:45 as **
  • Genomic signatures to guide the use of chemotherapeutics.
    Nat Med (22 October 2006)
    by Anil Potti, Holly K K Dressman, Andrea Bild, Richard F F Riedel, Gina Chan, Robyn Sayer, Janiel Cragun, Hope Cottrill, Michael J J Kelley, Rebecca Petersen, David Harpole, Jeffrey Marks, Andrew Berchuck, Geoffrey S S Ginsburg, Phillip Febbo, Johnathan Lancaster, Joseph R R Nevins
    posted to therapy by jfr on 2006-11-07 12:06:10 as read along with 5 people and 3 groups jyuh kengg giovanni frohike mgaldzic GeschwindLab CHIP Plantandetc
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/jfr/tag/therapy

    RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.